11:00 | P707 | Endothelial function and testosterone deficiency in men with type 2 diabetes mellitus | Irina KHRIPUN (Rostov-On-Don, Russian Federation) |
|
11:00 | P708 | Identification of 26 novel loci that confer susceptibility to early-onset coronary artery disease in a Japanese population | Mitsutoshi OGURI (Nagoya, Japan) |
|
11:00 | P709 | Improvement in endothelial function and arterial elastic properties facilitates response to cardiac resynchronization therapy | Nikolaos KARAMICHALAKIS (Athens, Greece) |
|
11:00 | P710 | S100A4, a key player in plaque stabilization? | Antonija SAKIC (Geneva, Switzerland) |
|
11:00 | P711 | Histamine promotes atherosclerotic plaque instability via STAT6-dependent macrophage pyroptosis | Lili XU (Shanghai, China) |
|
11:00 | P712 | Non-neuronal cholinergic system prevents coronary vascular dysfunction in diabetic heart | Eng Leng SAW (Dunedin, New Zealand) |
|
11:00 | P713 | Short term treatment of a low dose erythropoietin improves vascular function in a rat model of insulin resistance | Hiroe TOBA (, Japan) |
|
11:00 | P714 | 2-AG impacts on endothelial cell activation and endothelial cell viability in vitro and impairs endothelial repair in vivo | Julian JEHLE (Bonn, Germany) |
|
11:00 | P715 | Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability | Sokrates STEIN (Schlieren, Switzerland) |
|
11:00 | P716 | Role of EDRFs in aortic and mesenteric arterial function of the UC Davis Type 2 Diabetic Mellitus (UCD-T2DM) male rats | Roshanak RAHIMIAN (Stockton, United States of America) |
|
11:00 | P717 | Glucagon-like peptide 1 (GLP-1) improves endothelial dysfunction and vascular inflammation in polymicrobial sepsis induced by cecal ligation and puncture (CLP) | Sebastian STEVEN (Mainz, Germany) |
|
11:00 | P718 | Genome-wide copy number profiling of atherosclerotic plaques | Aleksei SLEPTCOV (Tomsk, Russian Federation) |
|
11:00 | P719 | Endothelial expression of adenylate cyclase type 9 (Adcy9) regulates endothelial cell signalling and vasodilation | Yohann RAUTUREAU (Montreal, Canada) |
|